ALPHA 1 LUNG DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Alpha 1 Lung Disease Market, By Disease Type (Alpha-1 Antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Fibrosis, Bronchiectasis, and Others), By Treatment Type (Augmentation Therapy, Bronchodilators, Corticosteroids, Oxygen Therapy, Lung Transplantation, and Others), By Route of Administration (Injectable, Oral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 29 Apr, 2026
Code: CMI6188
Page number: 165
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Alpha 1 Lung Disease, By Disease Type
  - Market Alpha 1 Lung Disease, By Treatment Type
  - Market Alpha 1 Lung Disease, By Route of Administration
  - Market Alpha 1 Lung Disease, By Distribution Channel
  - Market Alpha 1 Lung Disease, By Region
- Coherent Opportunity Map (COaM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
    - Rising Prevalence of COPD Globally
    - Increasing Diagnosis Rates
    - New Product Launches
    - Strong Pipeline of Drugs
  - Restraints
    - Limited awareness about the disease among the general population
  - Opportunities
    - Technological advancements in diagnostic techniques
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Alpha 1 Lung Disease
- Supply Side and Demand Side Analysis
- Economic Impact
Alpha 1 Lung Disease
Market, By
Disease Type
, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Alpha-1 Antitrypsin Deficiency
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Chronic Obstructive Pulmonary Disease (COPD)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pulmonary Fibrosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Bronchiectasis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Alpha 1 Lung Disease
Market, By
Treatment Type
,
2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Augmentation Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Bronchodilators
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Corticosteroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Oxygen Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Lung Transplantation
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Alpha 1 Lung Disease
Market, By
Route of Administration
,
2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Alpha 1 Lung Disease
Market, By
Distribution Channel
,
2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
Alpha 1 Lung Disease
Market, By
Region, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Country 2022-2033
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bristol-Myers Squibb
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company Limited.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- CSL Behring
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Vertex Pharmaceuticals Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Gilead Sciences, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Regeneron Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 44 market data tables and 41 figures on “Alpha 1 Lung Disease Market” - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now